Eisler Capital (Us) LLC Bristol Myers Squibb CO Put Options Transaction History

Eisler Capital (Us) LLC

  • $4.67 Trillion
  • Q3 2024

Put Options

4 transactions
Quarter Operation Price Per put puts change puts Held SEC Form
Q3 2024

Nov 14, 2024
BUY
$39.66 - $51.75 $4.85 Million - $6.32 Million
122,200 Added 568.37%
143,700 $7.44 Billion
Q2 2024

Aug 13, 2024
SELL
$40.25 - $52.99 $32,200 - $42,392
-800 Reduced 3.59%
21,500 $893 Million
Q1 2024

May 14, 2024
BUY
$47.98 - $54.4 $1.07 Million - $1.21 Million
22,300 New
22,300 $1.21 Billion
Q2 2023

Aug 14, 2023
BUY
$63.71 - $70.74 $248,469 - $275,886
3,900 New
3,900 $249 Million

Others Institutions Holding BMY

# of Institutions
2,536
Shares Held
1.47B
Call Options Held
31.6M
Put Options Held
35M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $123B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Eisler Capital (Us) LLC Portfolio

Follow Eisler Capital (Us) LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Eisler Capital (Us) LLC, based on Form 13F filings with the SEC.

News

Stay updated on Eisler Capital (Us) LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email